Takeda Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Takeda Pharmaceutical Co. Ltd.
Nomura Asset TOPIX ETF Fund (1306)
11,634,600
1.46%
184,200
0.68%
07/31/2018
Vanguard Total International Stock Index Fund
10,830,492
1.36%
143,300
0.13%
07/31/2018
Vanguard Health Care Fund
10,010,100
1.26%
-571,600
0.84%
06/30/2018
Nomura Asset NIKKEI 225 Index ETF (1321)
9,444,000
1.19%
128,000
0.76%
07/31/2018
Government Pension Fund - Global (The)
8,638,557
1.09%
227,499
0.04%
12/31/2017
Daiwa Asset TOPIX Listed ETF (1305)
5,710,600
0.72%
136,600
0.69%
07/31/2018
Causeway International Value Fund
5,595,500
0.7%
1,048,500
2.87%
06/30/2018
Nikko Asset Listed Index TOPIX ETF (1308)
5,240,100
0.66%
0
0.69%
08/20/2018
Nikko Asset Listed Index 225 ETF (1330)
4,790,000
0.6%
2,000
0.75%
08/20/2018
Vanguard Developed Markets Index Fund
4,297,182
0.54%
-3,620
0.16%
07/31/2018
| Address |
4-1-1 Dosho-machi
Osaka Osaka 540
Japan
|
|
Employees
|
- |
| Website |
http://www.takeda.co.jp |
| Updated |
07/08/2019 |
| Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. |
